Abstract:
Introduction: Unstable Angina (UA) is a form of acute coronary syndrome and is a major cause
of mortality. It is in increase due to the growing prevalence of many risk factors for
coronary failure, such as diabetes mellitus (DM), which aggravates the underlying
mechanisms of atherosclerosis.
DM has negative effects on most
metabolic pathways and contributes to
the multiple complications of this
disease. This is caused by:
(1) insulin resistance
(2) hyperglycemia
(3) metabolic syndrome
(4) endothelial dysfunction
(5) hyper coagulation.
Chronic hyperglycemia and insulin resistance are playing an important role in
initiating vascular complications of diabetes and involve certain mechanisms
including:
(1) increased formation of advanced glycation products and activation of advanced
glycation product receptors,
(2) oxidative stress
(3) inflammation.
Purpose: Study of the features of clinical evolution, diagnosis and
treatment of patients with unstable angina and type 2
diabetes mellitus.
Material and Methods:
This study was performed on a group of 60 patients diagnosed with Unstable
Angina, 30 of them with and 30 without DM, hospitalized between May - October
2018, within the Holy Trinity Municipal Hospital.
Symptoms, complications, laboratory and instrumental diagnosis, drug and
interventional treatment were compared.
In the study group,
there are more women –
35, i.e. 58%, in comparison
with men - 25 (42%). The
mean age of the patients -
68.9 years (± 20 years).
Results:
The clinical status of patients with diabetes and UA includes certain features.
Cardiac ischemia in diabetics compared to those without diabetes is more common
with atypical or silent symptoms with an unfavorable prognosis.
For people with diabetes, the recognition of cardiac symptoms may be more
difficult due to autonomic cardiac neuropathy, which leads to a subsequent decrease
in the symptoms experienced, silent ischemia and chronic symptoms associated with
diabetes.
Although chest pain is the classic symptom of UA, atypical symptoms such as
dyspnea, weakness and fatigue are vague symptoms which are characteristic of a
large number of diseases.
The "atypical" symptoms, in
the absence of chest pain, could
contribute to a delay requiring
urgent care, which leads patients
to believe that their symptoms are
harmless.
The most common complications in
patients with UA and DM are atrial
fibrillation and heart failure (HF).
Favoring their appearance is determined
by the low glucose tolerance and insulin
resistance that can lead to electrical and
structural remodeling with favoring the
appearance of rhythm disorders.
Patients with diabetes are more
likely to develop HF and have a much
worse NYHA functional class and
more HF-related symptoms and signs
compared to those without diabetes.
Also, patients with DM more
frequently have aortic induration, LVH,
hypokinesia, dyskinesia and impaired
relaxation. These results can be
explained by the toxic effects of
hyperglycemia and hyperlipidemia
characteristic of diabetes with direct
impairment of cardiac function.
A specific feature of patients with
diabetes is a more severe coronary
multivascular damage and the
involvement of more coronary
segments than those without diabetes.
Other studies have shown that
myocardial revascularization by PCI or
CABG improves angina more
efficiently compared to a strategy based
only on drug treatment. CABG is
considered to be more effective in
multivascular lesions and is a preferable
treatment in patients with diabetes.
Conclusion:
1) Clinical-evolutionary features in patients with unstable angina associated with
diabetes involve lower pain intensity, atypical clinical manifestations and
frequent development of complications such as atrial fibrillation and heart
failure.
2) Most patients who have benefited of invasive treatment are part of the group
of patients with diabetes, due to the more frequent presence of multivascular
lesions, involving small vessels.
Description:
Cardiology discipline, State University of Medicine and Pharmacy "Nicolae Testemitanu" Chișinău, Republic of Moldova, Universitatea ”Transilvania”, Brașov, România, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare